Title : A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer.

Pub. Date : 2014 Sep

PMID : 25295126






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 INTRODUCTON: The COU-AA-301 trial showed that abiraterone acetate (abiraterone), an oral cytochrome p450 CYP17 inhibitor, improved survival for men with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens